Georgia vs Sierra Leone: HIV-positive TB patients on ART (antiretroviral therapy)
Georgia
100.0%
in 2024
Sierra Leone
100.0%
in 2024
Georgia rank
1st
Sierra Leone rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Georgia
- Sierra Leone
How they compare
Georgia currently reports 100.0% against 100.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Georgia ahead.
Georgia ranks 1st and Sierra Leone ranks 1st of 144 countries.
Across the 3 decades both report, Georgia averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Georgia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.0% | 13.0% | 42.0% | Georgia |
| 2010s | 89.8% | 69.6% | 20.2% | Georgia |
| 2020s | 96.6% | 100.0% | 3.4% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Georgia or Sierra Leone?
- Georgia, at 100.0% against 100.0% in Sierra Leone as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Georgia and Sierra Leone?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Sierra Leone?
- 16 years are reported by both, from 2009 to 2024.
- How do Georgia and Sierra Leone rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Georgia ranks 1st and Sierra Leone ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.